![Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials - Respiratory Medicine Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/63295e6f-8cdc-41e9-993a-096b039f1f0a/gr1.jpg)
Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials - Respiratory Medicine
![Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design | SpringerLink Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-019-01093-3/MediaObjects/12325_2019_1093_Fig1_HTML.png)
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design | SpringerLink
![Frontiers | Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis | Cell and Developmental Biology Frontiers | Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/639657/fcell-09-639657-HTML/image_m/fcell-09-639657-g001.jpg)
Frontiers | Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis | Cell and Developmental Biology
![Timeline for landmark trials for antifibrotic therapy for idiopathic... | Download Scientific Diagram Timeline for landmark trials for antifibrotic therapy for idiopathic... | Download Scientific Diagram](https://www.researchgate.net/publication/342482080/figure/fig3/AS:960119865106433@1605921822019/Timeline-for-landmark-trials-for-antifibrotic-therapy-for-idiopathic-pulmonary-fibrosis.png)
Timeline for landmark trials for antifibrotic therapy for idiopathic... | Download Scientific Diagram
![Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c887906a-67bc-4cf3-92ed-ad962226488f/fx1_lrg.jpg)
Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development
![Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment for Usual Interstitial Pneumonia Clinical Trial | Power Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment for Usual Interstitial Pneumonia Clinical Trial | Power](https://pwr-og-img.withpower.com/Apply%20to%20this%20Phase%202%20clinical%20trial%20treating%20Pulmonary%20Fibrosis,%20Idiopathic%20Pulmonary%20Fibrosis,%20Fibrosis:%0A%0AHyperpolarized%20129%20Xenon%20Gas%20Comparing%20Idiopathic%20Pulmonary%20Fibrosis%20(IPF)%20Treatment%20for%20Usual%20Interstitial%20Pneumonia.png?md=1)
Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment for Usual Interstitial Pneumonia Clinical Trial | Power
![Pirfenidone in idiopathic pulmonary fibrosis: A phase III clinical trial in Japan | Semantic Scholar Pirfenidone in idiopathic pulmonary fibrosis: A phase III clinical trial in Japan | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2cb5d420e87ea20215f49708d65589b40cde29f8/25-Table1-1.png)
Pirfenidone in idiopathic pulmonary fibrosis: A phase III clinical trial in Japan | Semantic Scholar
![Guidelines for the Medical Treatment of Idiopathic Pulmonary Fibrosis | Archivos de Bronconeumología Guidelines for the Medical Treatment of Idiopathic Pulmonary Fibrosis | Archivos de Bronconeumología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1579212917300782:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9zfHQrK7O1GixshFj/RYvvhfIeFLIshOrwnoGDwJytw3sGm8bijV+TbKpnl+SctEdyqVW1pSNrrpMxTg3fw2zl9h3EUclbCOdZji7AP/Ospj+78dWe7Q7mzcAO/mmK/+Ccs21KSdOC8hn85aK/JnJc+g2UG+iIPFlEX0xgzuFYvlGwRNFIEnMSdAXVgUTMa4cD4BYatgEVFcOZwU+zTgQYQxTSaf6fG6iRt021VOToOdqAGvkUNWrahuG+OJEtUEZdSwVygihaBMINi4jO9puWQ=)
Guidelines for the Medical Treatment of Idiopathic Pulmonary Fibrosis | Archivos de Bronconeumología
![Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society](https://erj.ersjournals.com/content/erj/50/4/1701209/F1.large.jpg?width=800&height=600&carousel=1)
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
![Idiopathic pulmonary fibrosis: current challenges and future perspectives | European Respiratory Society Idiopathic pulmonary fibrosis: current challenges and future perspectives | European Respiratory Society](https://err.ersjournals.com/content/errev/22/128/103/F1.large.jpg)
Idiopathic pulmonary fibrosis: current challenges and future perspectives | European Respiratory Society
![COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12272-021-01331-9/MediaObjects/12272_2021_1331_Fig1_HTML.png)